Dmitry Kissin is the Team Lead of the Assisted Reproductive Technology (ART) Surveillance and Research Team in Women’s Health and Fertility Branch, Division of Reproductive Health, Centers for Disease Control and Prevention (CDC). ART Team is responsible for the National ART Surveillance System that monitors effectiveness and safety of ART in the United States. Dr. Kissin is involved in wide-ranging epidemiological and clinical research in the field of reproductive epidemiology. His research focuses on public health aspects of fertility treatments, including access to reproductive care, prevention of iatrogenic multiple births, and long-term health outcomes of fertility treatments. Dr. Kissin currently serves as CDC Principal Investigator in the States Monitoring ART (SMART) Collaborative – a multi-state project aimed at linking information between ART surveillance, state birth records, and disease registries to develop population-based research and state-based surveillance of maternal and infant health outcomes of ART.
Dr. Kissin received his Doctor of Medicine degree (specialization in Obstetrics and Gynecology) from the St. Petersburg State Medical University in Russia and Master of Public Health degree (specialization in Epidemiology) from the State University of New York in the United States. In 2003, Dr. Kissin joined the CDC as an Epidemic Intelligence Service (EIS) officer. At CDC, Dr. Kissin worked on a variety of projects, both domestically and internationally, in the areas of women’s health and maternal and child health, ranging from family planning, prevention of mother-to-child HIV transmission, prevention of influenza among pregnant women, and most recently – infertility and ART.